Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 2Other hematologic neoplasm 1Lymphoid 1Head & Neck 1Gynecologic 1Gastrointestinal 1Dermatologic 1

Conditions

Squamous Cell Carcinoma of Head and Neck 17Head and Neck Neoplasms 14Nasopharyngeal Carcinoma 8Carcinoma, Non-Small-Cell Lung 5Thyroid Neoplasms 4Stomach Neoplasms 4Salivary Gland Neoplasms 4Neoplasms 4Nasopharyngeal Neoplasms 4Esophageal Neoplasms 4Radiation Injuries 3Neoplasm Metastasis 3Melanoma 3Esthesioneuroblastoma, Olfactory 3Colorectal Neoplasms 3Uterine Cervical Neoplasms 2Triple Negative Breast Neoplasms 2Tongue Neoplasms 2Thyroid Carcinoma, Anaplastic 2Pharyngeal Neoplasms 2Pancreatic Neoplasms 2Ovarian Neoplasms 2Mouth Neoplasms 2Lymphoid Interstitial Pneumonia 2Endometrial Neoplasms 2Carcinoma, Transitional Cell 2Carcinoma, Squamous Cell 2Carcinoma, Renal Cell 2Carcinoma, Merkel Cell 2Carcinoma 2

Interventions

Filgrastim 3belinostat 2Gemcitabine 2Docetaxel 2Carboplatin 2toripalimab 1etoposide phosphate 1durvalumab 1capivasertib 1Topotecan 1Thiotepa 1Thalidomide 1Taxes 1Quality of Life 1Peripheral Blood Stem Cell Transplantation 1Patient Reported Outcome Measures 1Paclitaxel 1Molecular Diagnostic Techniques 1Medicare Part B 1Immunotherapy 1Immunoglobulin G 1Ifosfamide 1Fluorouracil 1Fentanyl 1Etoposide 1Drug Therapy 1Disulfides 1Cyclophosphamide 1Cryosurgery 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Chondrosarcoma × Bevacizumab × Head & Neck × Clear all
NCT05039801 2026-06-01

IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors

M.D. Anderson Cancer Center

Phase 1 Recruiting
54 enrolled
DermatologicGynecologicHead & NeckSarcoma

Squamous Cell Carcinoma of Head and Neck, Chondrosarcoma, Melanoma, Ovarian Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡